Evidence map›Paper›PMID 38577901›Full record

ArticleSchizophrenia bulletin2024

Distinct Volume Alterations of Thalamic Nuclei Across the Schizophrenia Spectrum.

Melissa Thalhammer, Julia Schulz, Felicitas Scheulen, Mohamed El Mehdi Oubaggi, Matthias Kirschner, Stefan Kaiser, André Schmidt, Stefan Borgwardt, Mihai Avram, Felix Brandl and 1 more

Abstract read
In one paragraph

Article in Schizophrenia bulletin, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Melissa ThalhammerDepartment of Diagnostic and Interventional Neuroradiology, School of Medicine, Technical University of Munich, Munich, Germany.ORCID 0000-0003-1950-4340
Julia SchulzDepartment of Diagnostic and Interventional Neuroradiology, School of Medicine, Technical University of Munich, Munich, Germany.
Felicitas ScheulenDepartment of Diagnostic and Interventional Neuroradiology, School of Medicine, Technical University of Munich, Munich, Germany.
Mohamed El Mehdi OubaggiDepartment of Diagnostic and Interventional Neuroradiology, School of Medicine, Technical University of Munich, Munich, Germany.
Matthias KirschnerDepartment of Psychiatry, University Hospital of Geneva, Geneva, Switzerland.ORCID 0000-0002-9486-1439
Stefan KaiserDepartment of Psychiatry, University Hospital of Geneva, Geneva, Switzerland.
André SchmidtDepartment of Psychiatry (UPK), University of Basel, Basel, Switzerland.ORCID 0000-0001-6055-8397
Stefan BorgwardtTranslational Psychiatry, Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.
Mihai AvramTranslational Psychiatry, Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.ORCID 0000-0003-2171-8313
Felix BrandlDepartment of Diagnostic and Interventional Neuroradiology, School of Medicine, Technical University of Munich, Munich, Germany.
Christian SorgDepartment of Diagnostic and Interventional Neuroradiology, School of Medicine, Technical University of Munich, Munich, Germany.

Funding

German Federal Ministry of Education and Research 01ER0803German Research Council SO1336/7McGill University P2SKP3_178175
6 · The paper itself

Abstract

background and hypothesisAbnormal thalamic nuclei volumes and their link to cognitive impairments have been observed in schizophrenia. However, whether and how this finding extends to the schizophrenia spectrum is unknown. We hypothesized a distinct pattern of aberrant thalamic nuclei volume across the spectrum and examined its potential associations with cognitive symptoms. STUDY

designWe performed a FreeSurfer-based volumetry of T1-weighted brain MRIs from 137 healthy controls, 66 at-risk mental state (ARMS) subjects, 89 first-episode psychosis (FEP) individuals, and 126 patients with schizophrenia to estimate thalamic nuclei volumes of six nuclei groups (anterior, lateral, ventral, intralaminar, medial, and pulvinar). We used linear regression models, controlling for sex, age, and estimated total intracranial volume, both to compare thalamic nuclei volumes across groups and to investigate their associations with positive, negative, and cognitive symptoms. STUDY

resultsWe observed significant volume alterations in medial and lateral thalamic nuclei. Medial nuclei displayed consistently reduced volumes across the spectrum compared to controls, while lower lateral nuclei volumes were only observed in schizophrenia. Whereas positive and negative symptoms were not associated with reduced nuclei volumes across all groups, higher cognitive scores were linked to lower volumes of medial nuclei in ARMS. In FEP, cognition was not linked to nuclei volumes. In schizophrenia, lower cognitive performance was associated with lower medial volumes.

conclusionsResults demonstrate distinct thalamic nuclei volume reductions across the schizophrenia spectrum, with lower medial nuclei volumes linked to cognitive deficits in ARMS and schizophrenia. Data suggest a distinctive trajectory of thalamic nuclei abnormalities along the course of schizophrenia.

Indexed as

Cognitive DysfunctionMagnetic Resonance ImagingPsychotic DisordersSchizophreniaThalamic NucleiAdolescentAdultFemaleHumansMaleYoung Adultcognitive symptomsmagnetic resonance imagingschizophreniathalamic nuclei

Identifiers

PMID38577901
PMCPMC11349018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.